AXM Pharma, Inc. (AXMP)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Apr 13, 2026
AXM Pharma Market Cap
AXM Pharma has a market cap or net worth of $1.04 million as of April 20, 2026.
Market Cap
1.04M
Enterprise Value
n/a
Revenue
110.68M
Ranking
n/a
PE Ratio
0.06
Stock Price
$0.00
Market Cap Chart
Since October 15, 2018, AXM Pharma's market cap has decreased from 206.09M to 1.04M, a decrease of -99.49%. That is a compound annual growth rate of -50.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 1.04M | - |
| Dec 3, 2025 | 1.04M | 9,899.62% |
| Dec 30, 2022 | 10.41K | -99.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 767.52M |
| Veradigm | 715.76M |
| Glass House Brands | 703.48M |
| CytoDyn | 508.16M |
| Full Alliance Group | 1.10M |
| Vitalibis | 1.09M |
| Nu-Med Plus | 1.09M |
| Eastgate Biotech | 1.06M |